The episode opens with a discussion of widespread virtualization (00:58), as the industry shifts focus from the rapid adoption precipitated by the COVID-19 crisis to operationalization and refinement of the customer experience, particularly as a generation of digital natives move into leadership positions and increasingly utilize healthcare services (03:06). At (06:30) the conversation shifts to business model and partnership innovation trends, as new and existing players look to unlock new opportunities across the value chain and become more agile in how they bring solutions to the marketplace (09:30). Organizations are diversifying their portfolios – pursuing multiple partnerships, working across sectors, and entering new spaces. Accompanying this is an innovation in care models (12:50), as the industry starts to reimagine healthcare as an interconnected ecosystem in response to increasing cost pressures and consumer demands. The healthcare hub model, whether pharmacy, health system, or IDN-driven, could be a key factor in success and sustainability in this new environment (16:05). Driving both the business and care model innovation trends is the industry shift to value as the differentiator (18:03) – the pandemic’s exposure of the risks of the fee-for-service model, the success of early CMS programs, and industry recognition that the system needs to change is likely to accelerate the operationalization and expansion (23:41) of value-based models. Beyond reimbursement, across the industry there is an acknowledgement of whole person care (24:40) – a recognition of the importance of social determinants of health and changing consumer preferences around health and wellness. Technology and data sharing are enabling the personalization of health (28:16) that today’s consumers are starting to demand when it comes to their care experience.
Trending News EU – 16 June 2022
DEI & Clinical Trials – Driving Meaningful Change
Integrating Diversity, Equity, & Inclusion Throughout Clinical Trials
Pharmaceutical companies who choose not to build DEI into their business strategy are missing out on an opportunity to expand the reach of life-changing therapies while isolating large populations of potential consumers. In this insight, Vynamic covers how to integrate DEI within key steps of the clinical trials process to facilitate better outcomes for both patients and pharmaceutical companies alike.
- Life Sciences
Prioritizing Diversity, Equity, & Inclusion Across Research & Development
Vynamic helped a large, global life sciences organization identify multiple opportunities to improve their DEI strategy within their R&D department, including a roadmap that went beyond diversity in hiring and retention, and included DEI principles applied to the "business of life sciences" to not only help advance client priorities, but also raise the bar for the pharmaceutical industry.
- Life Sciences
Trending News – June 2nd, 2022
Activating Diversity, Equity, & Inclusion Through Employee Resource Councils
The leadership of a large home healthcare provider sought to operationalize their Diversity, Equity, & Inclusion (DEI) strategy across their organization. Read how Vynamic helped this organization activate Employee Resource Councils, successfully onboard a DEI leader, and introduce internal DEI branding.
Trending News – May 19, 2022
Innovations Across the Atlantic: What the US & UK Can Learn From Each Other When it Comes to Crisis Care
Unlocking Patient Access Through The Digital Front Door
Patient access is one of the most critical issues plaguing the current healthcare industry. A large, academic medical center and nationally-recognized integrated delivery network sought Vynamic's help to create innovative solutions to enable optimal patient access, opening the door to increasing health equity.
Want to learn more? Get in Touch!
Contact our team to learn more about how we can help your needs.